These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

715 related articles for article (PubMed ID: 10615932)

  • 41. Failure to adhere to protocol specified radiation therapy guidelines was associated with decreased survival in RTOG 9704--a phase III trial of adjuvant chemotherapy and chemoradiotherapy for patients with resected adenocarcinoma of the pancreas.
    Abrams RA; Winter KA; Regine WF; Safran H; Hoffman JP; Lustig R; Konski AA; Benson AB; Macdonald JS; Rich TA; Willett CG
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):809-16. PubMed ID: 21277694
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Open-label, multicenter, randomized phase III trial of adjuvant chemoradiation plus interferon Alfa-2b versus fluorouracil and folinic acid for patients with resected pancreatic adenocarcinoma.
    Schmidt J; Abel U; Debus J; Harig S; Hoffmann K; Herrmann T; Bartsch D; Klein J; Mansmann U; Jäger D; Capussotti L; Kunz R; Büchler MW
    J Clin Oncol; 2012 Nov; 30(33):4077-83. PubMed ID: 23008325
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Adjuvant chemoradiotherapy for "unfavorable" carcinoma of the ampulla of Vater: preliminary report.
    Mehta VK; Fisher GA; Ford JM; Poen JC; Vierra MA; Oberhelman HA; Bastidas AJ
    Arch Surg; 2001 Jan; 136(1):65-9. PubMed ID: 11146780
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Patterns of failure in grossly resected pancreatic ductal adenocarcinoma treated with adjuvant irradiation +/- 5 fluorouracil.
    Foo ML; Gunderson LL; Nagorney DM; McLlrath DC; van Heerden JA; Robinow JS; Kvols LK; Garton GR; Martenson JA; Cha SS
    Int J Radiat Oncol Biol Phys; 1993 Jun; 26(3):483-9. PubMed ID: 8390422
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Concomitant radiotherapy with protracted 5-fluorouracil infusion in locally advanced carcinoma of the pancreas: a phase II study.
    Osti MF; Costa AM; Bianciardi F; De Nicolò M; Donato V; Silecchia G; Enrici RM
    Tumori; 2001; 87(6):398-401. PubMed ID: 11989594
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Surgery and multimodal treatments in pancreatic cancer--a review on the basis of future multimodal treatment concepts.
    Link KH; Leder G; Formentini A; Fortnagel G; Kornmann M; Schatz M; Beger HG
    Gan To Kagaku Ryoho; 1999 Jan; 26(1):10-40. PubMed ID: 9987495
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Adjuvant therapy for pancreatic cancer: to treat or not to treat?
    Berlin JD
    Oncology (Williston Park); 2007 May; 21(6):712-8; discussion 720, 725-6, 730. PubMed ID: 17564327
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Meta-analysis of adjuvant therapy following curative surgery for periampullary adenocarcinoma.
    Acharya A; Markar SR; Sodergren MH; Malietzis G; Darzi A; Athanasiou T; Khan AZ
    Br J Surg; 2017 Jun; 104(7):814-822. PubMed ID: 28518410
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Long-term follow-up of twenty patients with adenocarcinoma of the pancreas: resection following combined modality therapy.
    Cooperman AM; Snady H; Bruckner HW; Hammerman H; Siegel J; Stark B; Bank S
    Surg Clin North Am; 2001 Jun; 81(3):699-708. PubMed ID: 11459283
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Is adjuvant 5-FU-based chemoradiotherapy for resectable pancreatic adenocarcinoma beneficial? A meta-analysis of an unanswered question.
    Khanna A; Walker GR; Livingstone AS; Arheart KL; Rocha-Lima C; Koniaris LG
    J Gastrointest Surg; 2006 May; 10(5):689-97. PubMed ID: 16713541
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Final results of a phase III clinical trial on adjuvant intraportal infusion with heparin and 5-fluorouracil (5-FU) in resectable colon cancer (EORTC GITCCG 1983-1987). European Organization for Research and Treatment of Cancer. Gastrointestinal Tract Cancer Cooperative Group.
    Nitti D; Wils J; Sahmoud T; Curran D; Couvreur ML; Lise M; Rauschecker H; dos Santos JG; Stremmel W; Roelofsen F
    Eur J Cancer; 1997 Jul; 33(8):1209-15. PubMed ID: 9301444
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Intensity-modulated radiotherapy for pancreatic adenocarcinoma.
    Abelson JA; Murphy JD; Minn AY; Chung M; Fisher GA; Ford JM; Kunz P; Norton JA; Visser BC; Poultsides GA; Koong AC; Chang DT
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):e595-601. PubMed ID: 22197234
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Role of adjuvant chemoradiotherapy for ampulla of Vater cancer.
    Kim K; Chie EK; Jang JY; Kim SW; Oh DY; Im SA; Kim TY; Bang YJ; Ha SW
    Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):436-41. PubMed ID: 19394162
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The treatment of pancreatic cancer.
    Yeo CJ; Cameron JL
    Ann Chir Gynaecol; 2000; 89(3):225-33. PubMed ID: 11079793
    [No Abstract]   [Full Text] [Related]  

  • 55. Randomized controlled trial of postoperative radiotherapy and short-term time-scheduled 5-fluorouracil against surgery alone in the treatment of Dukes B and C rectal cancer. Norwegian Adjuvant Rectal Cancer Project Group.
    Tveit KM; Guldvog I; Hagen S; Trondsen E; Harbitz T; Nygaard K; Nilsen JB; Wist E; Hannisdal E
    Br J Surg; 1997 Aug; 84(8):1130-5. PubMed ID: 9278661
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma? A phase III multicenter prospective randomized controlled trial in patients with resected pancreaticobiliary carcinoma.
    Takada T; Amano H; Yasuda H; Nimura Y; Matsushiro T; Kato H; Nagakawa T; Nakayama T;
    Cancer; 2002 Oct; 95(8):1685-95. PubMed ID: 12365016
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Histopathological response to preoperative chemoradiation for resectable pancreatic adenocarcinoma: the French Phase II FFCD 9704-SFRO Trial.
    Le Scodan R; Mornex F; Partensky C; Mercier C; Valette PJ; Ychou M; Roy P; Scoazec JY
    Am J Clin Oncol; 2008 Dec; 31(6):545-52. PubMed ID: 19060585
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Predictors of long-term survival after pancreaticoduodenectomy for peri-ampullary adenocarcinoma: A retrospective study of 5-year survivors.
    El Nakeeb A; El Sorogy M; Ezzat H; Said R; El Dosoky M; Abd El Gawad M; Elsabagh AM; El Hanafy E
    Hepatobiliary Pancreat Dis Int; 2018 Oct; 17(5):443-449. PubMed ID: 30126828
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Intraoperative and conformal external-beam radiation therapy with protracted 5-fluorouracil infusion in patients with locally advanced pancreatic carcinoma.
    Furuse J; Kinoshita T; Kawashima M; Ishii H; Nagase M; Konishi M; Nakagohri T; Inoue K; Ogino T; Ikeda H; Maru Y; Yoshino M
    Cancer; 2003 Mar; 97(5):1346-52. PubMed ID: 12599244
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Adjuvant 5-FU-based chemoradiotherapy for patients undergoing R-1/R-2 resections for pancreatic cancer.
    Smeenk HG; Incrocci L; Kazemier G; van Dekken H; Tran KT; Jeekel J; van Eijck CH
    Dig Surg; 2005; 22(5):321-8. PubMed ID: 16254431
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.